A new review highlights the potential role of single nucleotide polymorphisms (SNPs) in improving the early diagnosis and targeted intervention of coronary microvascular dysfunction (CMD)—a condition ...
Fast-RSOM skin scan identifies early cardiovascular risk by imaging tiny blood vessels and functional changes before symptoms ...
SAN DIEGO and STOCKHOLM, Aug. 21, 2025 /PRNewswire/ -- CVCO Therapeutics, Inc., a clinical-stage pharmaceutical company focused on microvascular disease, and Karolinska University Hospital, one of the ...
Invasive coronary functional testing to identify the cause of angina in patients with nonobstructive coronary artery disease (ANOCA) can be performed safely at both experienced and less-experienced ...
ROCHESTER, Minn. — A study at Mayo Clinic suggests that an hourglass-shaped stent could improve blood flow and ease severe and reoccurring chest pain in people with microvascular disease. Of 30 ...
(MENAFN- GetNews) The Key Coronary Microvascular Dysfunction Companies in the market include - Caladrius Biosciences, AbbVie, Coroventis, XyloCor Therapeutics, Cardiovascular Systems Inc., Akcea ...
VahatiCor's A-FLUX Reducer System® is a coronary sinus reducer designed to enhance myocardial perfusion. By creating a controlled narrowing of the coronary sinus, the device was engineered to optimize ...
Exercise electrocardiographic (ECG) stress tests appeared to reliably indicate that some patients with angina with nonobstructive coronary arteries (ANOCA) actually had coronary microvascular ...
LOS ANGELES (KABC) -- Doctors know how to spot large artery blockages when someone is experiencing heart attack symptoms, but often not those in the smaller heart ...
Garden-variety exercise stress testing can be used in patients who have angina with nonobstructive coronary arteries (ANOCA) to uncover the presence of coronary microvascular dysfunction (CMD), new ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results